Reduced immunogenicity of a third COVID-19 vaccination among recipients of allogeneic hematopoietic stem cell transplantation

• Sigrun Einarsdottir,
• Anna Martner,
• Malin Nicklasson,
• Hanna Grauers Wiktorin,
• Mohammad Arabpour,
• Andreas Törnell,
• Krista Vaht,
• Jesper Waldenström,
• Johan Ringlander,
• Tomas Bergström,
• Mats Brune,
• Kristoffer Hellstrand,
• Per Ljungman,
• Martin Lagging

Affiliations

Sigrun Einarsdottir

Department of Hematology and Coagulation, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg

Anna Martner

TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg

Malin Nicklasson

Department of Hematology and Coagulation, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg

Hanna Grauers Wiktorin

TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg

Mohammad Arabpour

TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg

Andreas Törnell

TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg

Krista Vaht

Department of Hematology and Coagulation, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg

Jesper Waldenström

Region Västra Götaland, Sahlgrenska University Hospital, Department of Clinical Microbiology, Gothenburg, Sweden; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg

Johan Ringlander

Region Västra Götaland, Sahlgrenska University Hospital, Department of Clinical Microbiology, Gothenburg, Sweden; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg

Tomas Bergström

Region Västra Götaland, Sahlgrenska University Hospital, Department of Clinical Microbiology, Gothenburg, Sweden; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg

Mats Brune

Department of Hematology and Coagulation, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg

Kristoffer Hellstrand

TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Clinical Microbiology, Gothenburg

Per Ljungman

Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Huddinge and Division of Hematology, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm

Martin Lagging

Region Västra Götaland, Sahlgrenska University Hospital, Department of Clinical Microbiology, Gothenburg, Sweden; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg